Insiders Lixte Biotechnology Holdings, Inc.

Equities

LIXT

US5393193017

Market Closed - Nasdaq Other stock markets 01:30:00 22/06/2024 am IST			5-day change	1st Jan Change
2.54 ^USD	+2.21%		+3.67%	+8.09%

14/06	Lixte Biotechnology Holdings, Inc. to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial	CI
06/06	Lixte Biotechnology Holdings, Inc. Reports Findings Show LIXTE's Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

LIXTE Biotechnology Holdings, Inc. Announces Executive Changes	03/06	CI
Lixte Biotechnology Names Bas van der Baan as Chief Executive	26/23/26	MT
Lixte Biotechnology Holdings, Inc. Announces Chief Executive Officer Changes	26/23/26	CI
Lixte Biotechnology Holdings, Inc. Announces Executive Changes	26/23/26	CI
Lixte Biotechnology Holdings, Inc. Promotes Eric Forman to Vice President and Chief Operating Officer	11/22/11	CI
Lixte Biotechnology Holdings, Inc. Appoints Bastiaan Van Der Baan as Independent Director	23/22/23	CI
Lixte Biotechnology Holdings, Inc. Appoints Bas Van Der Baan to Its Board of Directors	21/22/21	CI
Lixte Biotechnology Holdings, Inc. Announces Appointment of Professor René Bernards to its Board of Directors	15/22/15	CI
Philip Palmedo Not to Stand for Re-Election as Director of Lixte Biotechnology Holdings, Inc	13/22/13	CI
Lixte Biotechnology Holdings, Inc. Appoints Regina Brown to Its Board of Directors	12/21/12	CI
Lixte Biotechnology Holdings, Inc. Appoints Stephen Forman as Member of the Audit Committee	14/21/14	CI
Lixte Biotechnology Holdings, Inc. Appoints Gil N Schwartzberg to Its Board of Directors	13/21/13	CI
Lixte Biotechnology Holdings, Inc. Appoints Robert Weingarten as Chief Financial Officer	19/20/19	CI
Lixte Biotechnology Holdings, Inc. Appoints Robert Weingarten as Company’S Vice President	19/20/19	CI
Lixte Biotechnology Holdings, Inc. Appoints James S. Miser as Chief Medical Officer, Effective August 1, 2020	21/20/21	CI
Lixte Biotechnology Holdings, Inc. Announces Executive Changes	08/18/08	CI
Lixte Biotechnology Holdings, Inc. Announces Resignation of Kathleen Mullinix from Board of Directors	28/16/28	CI
Lixte Biotechnology Holdings, Inc. Appoints Stephen J. Forman to Board of Directors	18/16/18	CI
Daniel Von Hoff Joins Lixte Biotechnology's Scientific Advisory Board	07/14/07	CI
Lixte Biotechnology Holdings, Inc. Appoints Kathleen Mullinix to its Board of Directors	27/12/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lixte Biotechnology Holdings, Inc.

Equities

LIXT

US5393193017

Insiders

Filters